Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis
about
Lysosomal multienzyme complex: pros and cons of working togetherPathogenesis, Emerging therapeutic targets and Treatment in Sialidosis.Genetic Manipulation of Brown Fat Via Oral Administration of an Engineered Recombinant Adeno-associated Viral Serotype Vector.Sialidosis type I: ophthalmological findings.
P2860
Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chaperone-mediated gene therap ...... use model of type I sialidosis
@en
Chaperone-mediated gene therap ...... se model of type I sialidosis.
@nl
type
label
Chaperone-mediated gene therap ...... use model of type I sialidosis
@en
Chaperone-mediated gene therap ...... se model of type I sialidosis.
@nl
prefLabel
Chaperone-mediated gene therap ...... use model of type I sialidosis
@en
Chaperone-mediated gene therap ...... se model of type I sialidosis.
@nl
P2093
P2860
P1476
Chaperone-mediated gene therap ...... use model of type I sialidosis
@en
P2093
Alessandra d'Azzo
Diantha van de Vlekkert
Elida Gomero
Erik J Bonten
Gouri Yogalingam
P2860
P304
P356
10.1016/J.BBADIS.2013.06.002
P407
P577
2013-06-12T00:00:00Z